Emerging evidence suggests that HSV-1 may contribute to neurodegeneration, particularly in AD, potentially through mechanisms such as chronic neuroinflammation, amyloid-beta (Aβ) and hyperphosphorylated Tau accumulation, oxidative stress, and synaptic dysfunction [5]. The gene discussed is MAPT; the disease is Alzheimer disease.